Published in J Virol on August 01, 1995
Dengue and dengue hemorrhagic fever. Clin Microbiol Rev (1998) 19.59
Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine. J Virol (2000) 1.79
Apoptosis in the mouse central nervous system in response to infection with mouse-neurovirulent dengue viruses. J Virol (1998) 1.73
Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3. J Virol (2000) 1.56
Genetic determinants responsible for acquisition of dengue type 2 virus mouse neurovirulence. J Virol (1998) 1.34
Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge. J Virol (1996) 1.28
Successful propagation of flavivirus infectious cDNAs by a novel method to reduce the cryptic bacterial promoter activity of virus genomes. J Virol (2011) 1.16
A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease. J Virol (2014) 0.99
Replacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidates. J Virol (1999) 0.97
RNA virus reverse genetics and vaccine design. Viruses (2014) 0.82
Molecular mechanism of pathogenesis of dengue virus: Entry and fusion with target cell. Indian J Clin Biochem (2005) 0.81
Role of cognitive parameters in dengue hemorrhagic fever and dengue shock syndrome. J Biomed Sci (2013) 0.80
Synergistic interactions between the NS3(hel) and E proteins contribute to the virulence of dengue virus type 1. PLoS Negl Trop Dis (2012) 0.80
Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence. J Virol (2016) 0.75
Research on dengue during World War II. Am J Trop Med Hyg (1952) 8.76
Viruses associated with epidemic hemorrhagic fevers of the Philippines and Thailand. Science (1960) 5.28
Molecular evolution and epidemiology of dengue-3 viruses. J Gen Virol (1994) 4.47
Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation. New Biol (1989) 4.46
PRODUCTION OF IMMUNITY TO DENGUE WITH VIRUS MODIFIED BY PROPAGATION IN MICE. Science (1945) 4.05
Cloning full-length dengue type 4 viral DNA sequences: analysis of genes coding for structural proteins. Virology (1986) 3.85
Complete nucleotide sequence of dengue type 3 virus genome RNA. Virology (1990) 3.58
The nucleotide sequence of dengue type 4 virus: analysis of genes coding for nonstructural proteins. Virology (1987) 3.51
Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus. Proc Natl Acad Sci U S A (1991) 2.97
Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it. Proc Natl Acad Sci U S A (1987) 2.26
Synthesis of proteins and glycoproteins in dengue type 2 virus-infected vero and Aedes albopictus cells. J Gen Virol (1985) 2.02
Hemorrhagic fever in Thailand; recent knowledge regarding etiology. Jpn J Med Sci Biol (1967) 1.94
Experimental studies on dengue. I. Isolation, identification and modification of the virus. J Infect Dis (1952) 1.93
Construction of intertypic chimeric dengue viruses by substitution of structural protein genes. Proc Natl Acad Sci U S A (1991) 1.87
Infectious Japanese encephalitis virus RNA can be synthesized from in vitro-ligated cDNA templates. J Virol (1992) 1.82
Genetic determinants of dengue type 4 virus neurovirulence for mice. J Virol (1993) 1.78
Adaptation of the New Guinea B strain of dengue virus to suckling and to adult swiss mice; a study in viral variation. Am J Trop Med Hyg (1952) 1.77
Localization of a neutralizing epitope on the envelope protein of dengue virus type 2. Virology (1994) 1.67
Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2. Virology (1990) 1.52
Virulence of a live dengue virus vaccine candidate: a possible new marker of dengue virus attenuation. J Infect Dis (1988) 1.37
The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites. Virology (1994) 1.33
Single amino acid codon changes detected in louping ill virus antibody-resistant mutants with reduced neurovirulence. J Gen Virol (1993) 1.28
Dengue in Greece in 1927 and 1928 and the pathogenesis of dengue hemorrhagic fever: new data and a different conclusion. Am J Trop Med Hyg (1986) 1.26
Studies on the glycosylation of flavivirus E proteins and the role of carbohydrate in antigenic structure. Virology (1987) 1.02
A note on sequential dengue infection, presumptive and proved, with report of an instance of a third proved attack in one individual. Indian J Med Res (1971) 0.88
Immunoglobulin synthesis by lymphoid cells transformed in vitro by Abelson murine leukemia virus. Cell (1979) 6.03
Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc Natl Acad Sci U S A (1981) 5.57
Deletion mutants of simian virus 40 generated by enzymatic excision of DNA segments from the viral genome. J Mol Biol (1974) 5.47
Altered methylation of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus. Proc Natl Acad Sci U S A (1971) 5.23
Identification of simian virus 40 protein A. J Virol (1977) 4.93
A map of temperature-sensitive mutants of simian virus 40. Virology (1975) 4.77
Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J Virol (1991) 4.63
Mapping temperature-sensitive mutants of simian virus 40: rescue of mutants by fragments of viral DNA. Virology (1974) 4.30
Mapping the spliced and unspliced late lytic SV40 RNAs. Cell (1978) 4.25
Sequence of interrupted and uninterrupted mRNAs and cloned DNA coding for the two overlapping nonstructural proteins of influenza virus. Cell (1980) 4.18
Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) (1990) 3.97
Erythromycin-inducible resistance in Staphylococcus aureus: requirements for induction. J Bacteriol (1971) 3.93
Splicing as a requirement for biogenesis of functional 16S mRNA of simian virus 40. Proc Natl Acad Sci U S A (1979) 3.89
Cloning full-length dengue type 4 viral DNA sequences: analysis of genes coding for structural proteins. Virology (1986) 3.85
Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol (1988) 3.84
The nucleotide sequence of dengue type 4 virus: analysis of genes coding for nonstructural proteins. Virology (1987) 3.51
Structure of an inducibly methylatable nucleotide sequence in 23S ribosomal ribonucleic acid from erythromycin-resistant Staphylococcus aureus. Biochemistry (1973) 3.19
A frizzled homolog functions in a vertebrate Wnt signaling pathway. Curr Biol (1996) 3.18
Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a. J Virol (1989) 3.03
Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology (1995) 2.99
Place of death: preferences among cancer patients and their carers. Soc Sci Med (2004) 2.87
Processing and expression of early SV40 mRNA: a role for RNA conformation in splicing. Cell (1979) 2.80
Volatilisation of mercury and organomercurials determined by inducible R-factor systems in enteric bacteria. Nature (1974) 2.77
Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region. Am J Trop Med Hyg (2001) 2.67
Escherichia coli mutants with altered control of alcohol dehydrogenase and nitrate reductase. J Bacteriol (1980) 2.61
Mapping of the two overlapping genes for polypeptides NS1 and NS2 on RNA segment 8 of influenza virus genome. Proc Natl Acad Sci U S A (1980) 2.60
Burst firing in midbrain dopaminergic neurons. Brain Res Brain Res Rev (1997) 2.59
Cryotherapy and laser treatment for acute retinopathy of prematurity: refractive outcomes, a longitudinal study. Br J Ophthalmol (1997) 2.57
Alteration of 23 S ribosomal RNA and erythromycin-induced resistance to lincomycin and spiramycin in Staphylococcus aureus. J Mol Biol (1973) 2.51
Magnesium transport in Escherichia coli. J Biol Chem (1971) 2.38
Cleavage of the dengue virus polyprotein at the NS3/NS4A and NS4B/NS5 junctions is mediated by viral protease NS2B-NS3, whereas NS4A/NS4B may be processed by a cellular protease. J Virol (1992) 2.33
Prolonged pneumococcal meningitis due to an organism with increased resistance to penicillin. Pediatrics (1976) 2.22
MR imaging in hydatid disease. AJR Am J Roentgenol (1991) 2.20
Deletion mutants of simian virus 40 defective in biosynthesis of late viral mRNA. Proc Natl Acad Sci U S A (1979) 2.19
Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology (2000) 2.15
Assessment of function in routine clinical practice: description of the COOP Chart method and preliminary findings. J Chronic Dis (1987) 2.14
Medical decision-making capacity in patients with mild cognitive impairment. Neurology (2007) 2.11
The POU domain transcription factor Brn-2 is required for the determination of specific neuronal lineages in the hypothalamus of the mouse. Genes Dev (1995) 2.11
Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity. J Virol (1993) 2.06
Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation (1996) 2.06
Proliferating cell nuclear antigen and Msh2p-Msh6p interact to form an active mispair recognition complex. Nat Genet (2000) 2.05
Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis. J Virol (1990) 2.05
Identification and catabolic activity of well-derived gasoline-degrading bacteria from a contaminated aquifer. Appl Environ Microbiol (1990) 2.01
Systematic review of the problems and issues of accessing specialist palliative care by patients, carers and health and social care professionals. Palliat Med (2004) 2.01
High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res (1986) 1.98
Growth-restricted dengue virus mutants containing deletions in the 5' noncoding region of the RNA genome. Virology (1995) 1.95
Conservation of the influenza virus membrane protein (M1) amino acid sequence and an open reading frame of RNA segment 7 encoding a second protein (M2) in H1N1 and H3N2 strains. Virology (1981) 1.94
Chromatin structure and gene expression. Proc Natl Acad Sci U S A (1996) 1.93
Cell surface expression of the influenza virus hemagglutinin requires the hydrophobic carboxy-terminal sequences. Cell (1982) 1.92
Permeability and susceptibility of Escherichia coli to beta-lactam compounds. Antimicrob Agents Chemother (1981) 1.91
Nonviral oligonucleotides at the 5' terminus of cytoplasmic influenza viral mRNA deduced from cloned complete genomic sequences. Cell (1980) 1.91
Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation (1999) 1.89
Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses. Proc Natl Acad Sci U S A (1992) 1.89
Manganese-resistant mutants of Escherichia coli: physiological and genetic studies. J Bacteriol (1972) 1.88
Epstein-Barr virus receptors on human pharyngeal epithelia. Lancet (1986) 1.88
Spliced and unspliced messenger RNAs synthesized from cloned influenza virus M DNA in an SV40 vector: expression of the influenza virus membrane protein (M1). Virology (1982) 1.87
Construction of intertypic chimeric dengue viruses by substitution of structural protein genes. Proc Natl Acad Sci U S A (1991) 1.87
Childhood respiratory illness and the home environment. II. Association between respiratory illness and nitrogen dioxide, temperature and relative humidity. Int J Epidemiol (1982) 1.82
At the crossroads: which direction for the hospices? Palliat Med (1994) 1.81
Genetic determinants of dengue type 4 virus neurovirulence for mice. J Virol (1993) 1.78
Functional expression in primate cells of cloned DNA coding for the hemagglutinin surface glycoprotein of influenza virus. Proc Natl Acad Sci U S A (1981) 1.75
Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence. Virology (1996) 1.74
Cleavage of dengue virus NS1-NS2A requires an octapeptide sequence at the C terminus of NS1. J Virol (1990) 1.73
Expression of dengue virus structural proteins and nonstructural protein NS1 by a recombinant vaccinia virus. J Virol (1987) 1.72
Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice. J Virol (1993) 1.72
Monitoring the safety of over the counter drugs. We need a better way than spontaneous reports. BMJ (2001) 1.70
Dengue virus, a flavivirus, propagates in human bone marrow progenitors and hematopoietic cell lines. Blood (1989) 1.69
Regulation of fatty acid degradation in Escherichia coli: analysis by operon fusion. J Bacteriol (1981) 1.69
Severe retinopathy of prematurity and its association with different rates of survival in infants of less than 1251 g birth weight. Arch Dis Child Fetal Neonatal Ed (2000) 1.69
Declining financial capacity in mild cognitive impairment: A 1-year longitudinal study. Neurology (2009) 1.69
The B/C gene of simian virus 40. Virology (1976) 1.67
Mapping the genes of simian virus 40. Cold Spring Harb Symp Quant Biol (1975) 1.66
Memories in sand: experimental tests of construction history on stress distributions under sandpiles. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics (1999) 1.66
Nucleotide sequence of the DNA replication origin for human papovavirus BKV: sequence and structural homology with SV40. Cell (1978) 1.61
Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation. Oncogene (2000) 1.61
The apparent role of blood transfusions in the development of retinopathy of prematurity. Eur J Pediatr (1993) 1.60
Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4. Proc Natl Acad Sci U S A (1998) 1.60
Improvement of endothelial function and insulin sensitivity with vitamin C in patients with coronary spastic angina: possible role of reactive oxygen species. J Am Coll Cardiol (2000) 1.59
Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease. Int J Radiat Oncol Biol Phys (1996) 1.57
Systemic effects of screening for retinopathy of prematurity. Br J Ophthalmol (1996) 1.57
Sequence of the influenza A/Udorn/72 (H3N2) virus neuraminidase gene as determined from cloned full-length DNA. Virology (1982) 1.56
Iontophoretically administered drugs acting at the N-methyl-D-aspartate receptor modulate burst firing in A9 dopamine neurons in the rat. Synapse (1992) 1.56
Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes. J Virol (1989) 1.55
Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene (2000) 1.54
Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins. J Biol Chem (1990) 1.54
Cloning DNA sequences from influenza viral RNA segments. Proc Natl Acad Sci U S A (1980) 1.54
Hepatitis B virus transcript produced by RNA splicing. J Virol (1989) 1.52
Impact of changing diagnostic criteria on incidence, management, and outcome of acute myocardial infarction: retrospective cohort study. BMJ (2003) 1.52
Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease. Circulation (1999) 1.50
Molecular analysis of external genitalia formation: the role of fibroblast growth factor (Fgf) genes during genital tubercle formation. Development (2000) 1.50
Expression of unspliced NS1 mRNA, spliced NS2 mRNA, and a spliced chimera mRNA from cloned influenza virus NS DNA in an SV40 vector. Virology (1984) 1.46
Escherichia coli mutants with a temperature-sensitive alcohol dehydrogenase. J Bacteriol (1982) 1.44
Tyrosine-48 is the proton donor and histidine-110 directs substrate stereochemical selectivity in the reduction reaction of human aldose reductase: enzyme kinetics and crystal structure of the Y48H mutant enzyme. Biochemistry (1994) 1.43
Aggressive jejunal lymphoma of large granular lymphocytes. Immunohistochemical, ultrastructural, molecular, and DNA content analysis. Am J Clin Pathol (1990) 1.42
An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42